Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Association of Dutch Burn Centres Valeant Pharmaceuticals International |
---|---|
Information provided by: | Association of Dutch Burn Centres |
ClinicalTrials.gov Identifier: | NCT00548210 |
The purpose of this research is to demonstrate effectivity of Dermatix in promoting maturation of the scar, versus a control region that will be treated with an indifferent cream.
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Dermatix; A Randomized Controlled Trial Measuring Effectivity of Dermatix in Promoting Scar Maturation of Hypertrophic Scars. |
Estimated Enrollment: | 25 |
The healing of deep thermal injuries is always associated with scarring. The healing process can lead to the formation of large scar bundles (e.g. hypertrophic scars). The scars can be discomforting, disfiguring and restrict motion if situated over or near joints. Evidence for effectivity of treatment for reduction of hypertrophic scars or the prevention of them is limited.
Different treatments are used such as intralesional injected steroids, topically used oily creams, silicone sheets or occlusive dressings. Compression garments are also frequently used. There is some evidence as to the effectivity of silicone sheets for recuction of hypertrophic scarring, however, these sheets cannot be used easily on all anatomical locations.
Valeant Pharmaceuticals International has developed a silicone based scar remodelling gel, Dermatix®, which has been empirically shown by others to have potential to reduce hypertrophic scars.
Primary objectives are to demonstrate effectivity of Dermatix in promoting maturation of the scar, versus a control region that will be treated with an indifferent cream.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion criteria:
Contact: Antoon van den Bogaerdt, PhD | +31 251 264917 | AvdBogaerdt@rkz.nl |
Contact: Esther Middelkoop, PhD | +31 251 265283 | EMiddelkoop@rkz.nl |
Netherlands, Noord-Holland | |
Association of Dutch Burn Centres | Recruiting |
Beverwijk, Noord-Holland, Netherlands, 1940 EB | |
Contact: Antoon van den Bogaerdt, PhD +31 251 264917 AvdBogaerdt@rkz.nl | |
Contact: Esther Middelkoop, PhD +31 251 264917 EMiddelkoop@rkz.nl | |
Principal Investigator: Antoon van den Bogaerdt, PhD |
Study Director: | Esther Middelkoop, PhD | Association of Dutch Burn Centres |
Study ID Numbers: | DERMO0501 |
Study First Received: | October 22, 2007 |
Last Updated: | October 22, 2007 |
ClinicalTrials.gov Identifier: | NCT00548210 |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Hypertrophy scarring scar treatment silicone |
Pathological Conditions, Anatomical Hypertrophy Cicatrix, Hypertrophic Skin Diseases Cicatrix |